Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Verona Pharma ( (VRNA)) has issued an ...
The Age of AI will rely on massive volumes of data that can be easily stored and retrieved—and bioscience may have an ingenious solution. A scientist examines a DNA (deoxyribonucleic acid) profile on ...
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) is one of the stocks Jim Cramer recently discussed. Verona Pharma plc ...
Verona Pharma (NASDAQ:VRNA) jumped over 20% after Merck (NYSE:MRK) announced it was buying the company for $10 billion, or $107 per American Depositary Share (ADS). VRNA stock currently trades at $104 ...
$VRNA insiders have traded $VRNA stock on the open market 28 times in the past 6 months. Of those trades, 0 have been purchases and 28 have been sales. Here’s a ...
VRNA's COPD drug Ohtuvayre shows impressive Q1'25 net sales of $71.3M in just its third quarter of sales, all but confirming the blockbuster future of the drug. Ongoing R&D and trials, including a ...
We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against the other stocks that ...
Americans with European heritage have long been able to pinpoint their ancestry through DNA testing, but it's only in recent years that those with African heritage have been able to trace their ...
Below is Validea's guru fundamental report for VERONA PHARMA PLC - ADR (VRNA). Of the 22 guru strategies we follow, VRNA rates highest using our P/B Growth Investor model based on the published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results